Unveiling gender differences in demand ischemia: a study in a rat model of genetic hypertension by Podesser, Bruno K. et al.
www.elsevier.com/locate/ejcts
European Journal of Cardio-thoracic Surgery 31 (2007) 298—304Unveiling gender differences in demand ischemia: a study in a
rat model of genetic hypertension
Bruno K. Podesser b, Mohit Jain a, Soeun Ngoy a, Carl S. Apstein a,, Franz R. Eberli c,*
aCardiac Muscle Research Laboratory, Whittaker Cardiovascular Institute, Department of Medicine, Boston University School of Medicine, MA, USA
b Ludwig Boltzmann Cluster for Cardiovascular Research, c/o Allgemeines Krankenhaus Wien, Medizinische Universita¨t Wien, Austria
cDepartment of Cardiology, Universita¨tsspital Zurich, Ra¨mistraße 100, 8091 Zurich, Switzerland
Received 14 June 2006; received in revised form 29 October 2006; accepted 30 October 2006; Available online 18 December 2006AbstractObjective: Female gender is associated with reduced tolerance against acute ischemic events and a higher degree of left ventricular
hypertrophy under chronic pressure overload. We tested whether female and male rats with left ventricular hypertrophy present the same
susceptibility to demand ischemia. Methods: Hearts from hypertrophied female and male salt-resistant and salt-sensitive Dahl rats (n = 8 per
group) underwent 30 min of demand ischemia induced by rapid pacing (7 Hz) and an 85% reduction of basal coronary blood flow, followed by
30 min of reperfusion on an isovolumic red cell perfused Langendorff model. Results: In female hearts, high-salt diet induced a pronounced
hypertrophy of the septum (2.38  0.09 vs 2.17  0.08 mm; p < 0.01), whereas male hearts showed the greatest increase in the anterior/
posterior wall of the left ventricle (LV) (3.19  0.22 vs 2.01  0.16 mm; p < 0.05) compared with salt-resistant controls. At baseline, LV-
developed pressure/g LV was significantly higher in female than male hearts (200  13 and 196  14 vs 161  10 and 152  15 mmHg g1;
p < 0.01), independent of hypertrophy, indicating greater contractility in females. During ischemia, LV-developed pressure decreased in all
groups; at the end of reperfusion, hypertrophied female andmale hearts showed higher developed pressures independent of gender (148  3 and
130  8 vs 100  7 and 85  6 mmHg; p < 0.01). In contrast, diastolic pressure wasmore pronounced in female than in male hypertrophied hearts
during ischemia and reperfusion (24  3 vs 12  2 mmHg; p < 0.01). Conlusions: In the pressure overload model of the Dahl salt-sensitive rat,
female gender is associated with a more pronounced concentric hypertrophy, whereas male hearts develop a more eccentric type of remodeling.
Although present at baseline, after ischemia/reperfusion systolic function is gender-independent but more determined by hypertrophy. In
contrast, diastolic function is gender-dependent and aggravated by hypertrophy, leading to pronounced diastolic dysfunction. We can conclude
that in the malignant setting of demand ischemia/reperfusion gender differences in hypertrophied hearts are unmasked: female hypertrophied
hearts are more susceptible to ischemia/reperfusion than males. To determine whether in female hypertensive patients with acute coronary
syndromes, diastolic dysfunction could contribute to the worse clinical course, further experimental and clinical studies are needed.
# 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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Cardiac hypertrophy and, in particular, left ventricular
hypertrophy (LVH) is an adaptive response to hypertension.
By increasing ventricular wall thickness, hypertrophy
distributes a pressure overload over a greater myocardial
cross-sectional area such that systolic wall stress, fiber
shortening, and stroke volume can remain normal despite the
increased load [1].
In experimental studies, female gender is associatedwith
more concentric hypertrophy under pressure overload [2,3],* Corresponding author. Tel.: +41 1 2552216; fax: +41 1 2554401.
E-mail address: franz.eberli@dim.usz.ch (F.R. Eberli).
 In memoriam Carl S. Apstein, our great teacher, mentor and friend, who
passed away in autumn 2005.
1010-7940/$ — see front matter # 2007 European Association for Cardio-Thoracic S
doi:10.1016/j.ejcts.2006.10.041after myocardial infarction (MI) [4] or post-MI with
hypertension [5] compared with males. In clinical studies,
hypertension in premenopausal women is associated with
increased concentric hypertrophy and contractile perfor-
mance compared withmen [6]. Similarly, in postmenopausal
women with systolic hypertension and aortic stenosis [7],
the pattern of hypertrophy is concentric, too. This
concentric pattern designates both an increase in left
ventricular mass index and an increase in relative wall
thickness, and results in a normalization of wall stress. In
contrast, the pattern seen in men with equivalent disease is
more consistent with a cardiomyopathic eccentric response
[7].
Female gender is also associated with greater suscept-
ibility to acute ischemic syndromes [8]. Data from the US
National Registry of Myocardial Infarction clearly indicate
that there is a gender-based difference in mortality: amongurgery. Published by Elsevier B.V. All rights reserved.
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women is twice that for men [9]. Similarly, in the GUSTO IIb
study women had more complications than men during
hospitalization and a higher mortality rate [10]. These
differences seem unrelated to the presence of estrogen,
since estrogen has been found to be protective of ischemia—
reperfusion (I/R) injury [11].
In pressure overload hypertrophy, I/R injury is increased,
whereby diastolic dysfunction is predominant [12,13]. The
extent of ischemic diastolic and systolic dysfunction is
dependent on the type of hypertrophy [14]. To this day, it is
unclear whether hypertension-induced hypertrophy leads
to similar gender differences as other models of pressure
overload with respect to development of LVH. In addition,
nothing is known about the susceptibility of hypertrophied
female and male hearts toward I/R injury. We hypothesized
that in hypertension-induced hypertrophy, females would
have increased concentric hypertrophy that increases the
susceptibility to ischemia—reperfusion injury. Using a
model of genetic hypertension we therefore investigated
the influence of gender (1) on the development and extent
of compensated LVH and (2) on the vulnerability to I/R
injury.2. Methods
2.1. Animal model
The Dahl salt-sensitive (DS) rat is an established experi-
mental model of hypertrophy [5,14]. DS rats develop
hypertension with low renin and aldosterone levels and
compensated LVH. The Dahl salt-resistant (DR) rat develops
neither hypertension nor hypertrophy and serves as age- and
sex-matched control group.
Inbred DS (male n = 8, female n = 8) and DR (male n = 8,
female n = 8) rats obtained from Harlan Sprague Dawley were
housed, one rat per cage, in the Animal Facility of Boston
University Medical Center as per the Guide for the Care and
Use of Laboratory Animals (NIH Publication No.85-23, revised
1996). As described previously [5,14], rats arrived at 8—9
weeks of age and were fed with low-salt diet (0.12% NaCl) for
1 week for acclimatization. The rats were then switched to
high-salt diet (7.8% NaCl) and water ad libidum for 4 weeks.
Systemic blood pressure was measured by tail-cuff method at
30 8C.
2.2. Isolated heart preparation
After 4 weeks of high-salt diet hemodynamic changes, left
ventricle (LV) remodeling, and tolerance to ischemia—
reperfusion injury were studied in the isolated isovolumically
beating (balloon in LV) heart preparation perfused with red
blood cells as previously described [12]. Briefly, rats were
injected intraperitoneally with sodium pentobarbital (1 ml,
15 mg ml1) and heparinized (300 IU) via the right iliacal
vein. The chest was opened rapidly, the heart excised, placed
in iced saline, weighed, the aortic cannula inserted and
perfusion started within 10 s retrogradely via the aortic root.
All coronary venous effluents were collected by a cannula in
the ligated pulmonary artery and measured by timedcollection. Two pacing electrodes were placed on the
epicardial surface and the hearts were paced according to
the study protocol (Grass Instruments, Model 59, Quincy, MA).
A fluid-filled latex balloon connected, to a Statham P23Db
pressure transducer (Statham Instruments, Hato Rey, Puerto
Rico) by a short, stiff polyethylene tubing was then placed
into the left ventricle through the mitral valve and fixed.
Coronary perfusion pressure was measured via a Statham
P23Db pressure transducer connected to the aortic cannula.
Coronary pressures, LV pressure, and its first derivative were
recorded on a multichannel recorder (Gould Cleveland,
Ohio).
2.3. Perfusion system and perfusate
The perfusion system has been described in detail [12].
Briefly, it consisted of a venous reservoir, a variable flow
pump, an oxygenator, a water-jacketed arterial reservoir,
and a filter of 20 mm pore size. The red blood cell perfusate
consisted of bovine red blood cells at a final hematocrite of
40% in Krebs—Henseleit buffer (in mM): NaCl 118, KCl 4.7,
CaCl2 2.0, KH2PO4 1.2, MgSO4 1.2, NaHCO3 26.6, glucose 5.5,
lactate 1.0, palmitic acid 0.4 (as a source for free fatty acid
metabolism), and 40 g l1 bovine serum albumin. Gentamicin
(0.02 g l1) was added to retard bacterial growths. The
perfusate was equilibrated with 20% O2, 3% CO2, and 77% N2
at 37 8C and pH 7.4.
2.4. Perfusion protocol
During baseline hearts were initially perfused at 80 mmHg
for the nonhypertrophied and at 100 mmHg for the
hypertrophied hearts. This ensured similar coronary blood
flow per LV mass (Table 2). Before the onset of ischemia (see
below), the perfusion mode was switched to constant flow
such that changes in perfusion pressure now indicated
changes in vascular resistance. At the end of baseline
perfusion, LV balloon volume was increased until a LVEDP of
10 mmHg. Thereafter, LV balloon volume was held constant.
Under these conditions, changes in LVEDP reflect changes in
diastolic chamber stiffness. After the demand ischemia
protocol, hearts were switched back to preischemic baseline
conditions (5 Hz) and reperfused for 30 min under these
stable conditions.
2.4.1. Demand ischemia protocol
Hearts were subjected to 30 min of low-flow ischemia at
15% of their initial coronary blood flow. To simulate demand
ischemia, pacing rate was increased from 5 Hz to 7 Hz after
5 min of ischemia and reduced to 5 Hz for the last 5 min of
ischemia. Dahl salt-sensitive rats are characterized by an
isoform-specific modulation of the Na+/K+-ATPase that
impairs sodium excretion from the myocytes [15]. We
hypothesized that tachycardia, therefore, would further
impair ischemic diastolic function secondary to a sodium
overload of the myocytes.
Hemodynamic measurements were performed according
to a fixed schedule and were paralleled by sampling of
arterial and venous (coronary sinus) perfusate to calculate
cumulative lactate production (mmol min1 g1 LV mass), as
described recently [12].
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Fig. 1. Changes in body weight and arterial blood pressure were monitored at
baseline, 2 weeks after high-salt diet and 2 weeks later, before sacrifice. In
panel A, differences between male and female rats can be seen already at
baseline (**p < 0.01). Whereas male rats continuously increase in body weight,
female rats grow slower. At the time of sacrifice, this difference in body weight
is even more pronounced (***p < 0.001). Hypertrophy does not influence
changes in body weight. Panel B shows the constant increase in arterial systolic
pressure in DS compared with DR rats measured by tail cuff. Already after 2
weeks, hypertension is detectable and becomes even more prominent after 4
weeks of high-salt diet in bothmale and female rats (#p < 0.05 and ##p < 0.01),2.4.2. Pressure—volume curves
Prior to ischemia and at the end of reperfusion, diastolic
pressure—volume relationship was determined over a range
of balloon filling volumes. Using an airtight Hamilton
syringe containing saline, left ventricular balloon volume
was increased by 0.02 ml increments up to an LVEDP of
40 mmHg. The diastolic pressures generated for given
volumes were used to describe a pressure—volume relation-
ship by an exponential curve and equation ( p = b  ekV)
according to a model of Fletcher et al. [16]. Individuals with
an R2 value greater than 0.95 were included. The formula
was solved for given pressures and a final exponential
pressure—volume relationship for each individual was
determined.
2.5. Fixation and histologic preparation
Following the postischemic pressure—volume experi-
ments, hearts were arrested in diastole through an infusion
of 1 ml high concentration KCl, flushed with 2 ml of saline,
perfused at 50 mmHg with 200 ml of 10% buffered formalin
acetate (Fisher Scientific), and fixed at a LVEDP of 5 mmHg.
After fixation, hearts were processed for histologic examina-
tion, cut into five sections of equal thickness, and stained
with hematoxylin and eosin. Morphometry was performed on
the mid-papillary muscle section of the heart using a digital
imaging and computer-aided quantification (Sigma Scan Pro
4.0).
2.6. Statistical analysis
Results were given as mean  SEM. Comparison of animal
characteristics were analyzed with a one-factor analysis of
variance and post-HOC tests (Tukey HSD and Fisher PLSD).
Comparison of pressure—volume relationship between
experimental groups was performed by two-factor analysis
of variance, and comparison of repeated hemodynamic
measurements was performed by two-factor analysis of
variance for repeated measurements. If overall analysis of
variance indicated a significant difference of groups or
interaction, values at specific time points were examined by
the method of least significant differences (Fisher PLSD). A
probability of p < 0.05 was considered to be significant. Two
symbols were used to identify gender-specific (*) and
hypertrophy-specific (#) differences.independent of gender.3. Results
3.1. Animal characteristics
Fig. 1 shows body weight (Fig. 1A) and systolic blood
pressures (Fig. 1B) before 2 weeks and 4 weeks after the
onset of high-salt diet. Body weight was smaller in females
compared with males. After 2 weeks of high-salt diet, female
and male DS rats had developed hypertension compared with
DR rats ( p < 0.05) that became even more pronounced after
4 weeks of high-salt diet ( p < 0.01, Fig. 1B). Hypertension-
induced LV hypertrophy, as assessed by an increased LV/body
weight ratio, was more pronounced in female than male
hearts (4.2  0.2 vs 3.7  0.1; p < 0.05; Table 1).In addition, the high-salt diet in female hearts induced a
pronounced hypertrophy of the septum (Table 1 and Fig. 2A),
whereas male hearts showed the greatest increase in the
anterior, posterior, and freewall of the LV (Table 1 andFig. 2A).
Compensated LVH was also observed by a leftward shift of the
diastolic pressure/volume curve in the DS groups. However,
female hearts were positioned significantly left to the
respective male hearts, indicating smaller LV cavities and,
therefore, amore concentric hypertrophy (p < 0.05; Fig. 3A).
3.2. Coronary blood flow
At baseline, coronary blood flow/g LV was similar in all
groups (Table 2). Accordingly, coronary blood flow/LV mass
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Table 1
Animal characteristics
THW (g) LV (g) LV/BW Septum (mm) A/P wall (mm) Free wall (mm) Septum/radius Tibia (mm)
mDR 1.45  0.06 1.07  0.07 2.9  0.1 1.84  0.12 2.01  0.16 1.73  0.16 0.51  0.05 4.1  0.1
mDS 1.59  0.06 1.22  0.07 3.7  0.1## 2.17  0.08# 3.19  0.22# 2.63  0.16# 0.84  0.07## 4.3  0.1
fDR 0.95  0.05** 0.76  0.04 ** 3.3  0.2 1.69  0.08 2.18  0.11 1.98  0.14 0.55  0.04 3.8  0.1 **
fDS 1.29  0.02##, ** 1.00  0.03##, ** 4.2  0.2##, * 2.38  0.09## 2.84  0.26# 2.49  0.12# 0.96  0.09## 3.9  0.1 **
mDR andmDS,male DR and DS; fDR and fDS, female DR and DS; THW, total heart weight; LV, left ventricle; LV/BW, left ventricle/body weight ratio; A/Pwall, anterior/
posterior wall.
* p < 0.05.
** p < 0.01 indicates differences between gender.
# p < 0.05.
## p < 0.01 indicates differences between hypertrophied and nonhypertrophied hearts of the same gender.was identical during demand ischemia and reperfusion.
Coronary perfusion pressure was significantly increased in
hypertrophied hearts, indicating an increased coronary
resistance during ischemia ( p < 0.01). During reperfusion
coronary perfusion pressure and resistance were normalized
in all groups except in female hypertrophied hearts, where it
increased slightly but not significantly (Table 2).
3.3. Systolic function
LV-developed pressure (systolic—diastolic LV pressure) was
similar in nonhypertrophied female and male hearts andFig. 2. Representative prints of female (panel A) and male (panel B) DS and DR
rats at mid-papillary level, stained with hematoxylin-eosin. Whereas in
females the hypertrophic response has its maximum in the septum (panel
A), male hearts show the most pronounced increase in the anterior, posterior,
and free wall of the LV (panel B).similarly increased in hypertrophied male and female hearts
(Fig. 4). When developed pressure was normalized for LV
mass (mmHg g1), female hearts developed higher pressures
than male hearts, independent of hypertrophy, suggesting a
higher contractility in female hearts (200  13 and 196  14
vs 161  10 and 152  15 mmHg g1, female DS and DR vs
male DS and DR; p < 0.01). During demand ischemia, LV-
developed pressure decreased to the same extent in all
groups and remained stable throughout ischemia. During
reperfusion, hypertrophied male and female hearts had
higher LV-developed pressures than nonhypertrophied hearts
(148  3 and 130  8 vs 100  7 and 85  6 mmHg; p < 0.01),
independent of gender. Maximal positive dp/dt (mmHg1)
paralleled LV-developed pressure (data not shown).Fig. 3. Before ischemia (panel A) end-diastolic pressure—volume relationship
of female hearts are positioned left of male hearts (*p < 0.05), indicating
smaller LV cavity size and more concentric hypertrophy in hypertensive hearts.
After ischemia (panel B) all curves have shifted to the left, indicating greater
myocardial stiffness. Female hearts are still positioned left of male hearts
(*p < 0.05).
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Table 2
Coronary blood flow and perfusion pressure
CBF/LV (m1 g1) Baseline Isch 5 Isch 30 Rep 30
mDR 2.59  0.17 0.39  0.03 0.39  0.03 2.59  0.17
mDS 2.38  0.14 0.36  0.02 0.36  0.02 2.38  0.14
fDR 2.63  0.24 0.39  0.04 0.39  0.04 2.63  0.24
fDS 2.33  0.11 0.35  0.02 0.35  0.02 2.33  0.11
CPP (mmHg) Baseline Isch 5 Isch 30 Rep 30
mDR 80  0 18.1  0.9 22.3  1.2 72  3.2
mDS 100  0## 25.7  1.7## 34.7  1.4## 97.1  2##
fDR 80  0 17  1.2 21.1  1.9 82.1  4.1
fDS 100  0## 28.3  1.6## 36.7  1.4## 110  12.3##
CBF/LV, coronary blood flow per LVmass; CPP, coronary perfusion pressure; Isch
5 and 30, 5 min of demand ischemia; Rep 30, 30 min of reperfusion.
## p < 0.01 indicates differences between hypertrophied and nonhypertro-
phied hearts of the same gender; other abbreviations see Table 1.
Fig. 5. Panel A shows the time course of end-diastolic pressure (mmHg).
Ischemic end-diastolic pressure increases more in hypertrophied than non-
hypertrophied female hearts (##p < 0.01) and male hypertrophied hearts
(*p < 0.05). Similarly during reperfusion female hypertrophied hearts exhibit
greater diastolic dysfunction than nonhypertrophied or male hearts. Panel B
shows the time course of end-diastolic pressure per LV mass (mmHg g1). When
normalized per LV mass female hearts develop more ischemic diastolic dys-
function than males, independent of hypertrophy (**p < 0.01).3.4. Diastolic function
During ischemia, LV diastolic pressure increased in all
groups (Fig. 5A). This increase in diastolic pressures was
higher in female hypertrophied than nonhypertrophied
hearts ( p < 0.05 and p < 0.01, respectively). In addition,
female hypertrophied hearts also had higher diastolic
pressures than male hypertrophied and nonhypertrophied
hearts ( p < 0.05 and p < 0.01, respectively). During
reperfusion, diastolic function improved in all groups.
However, it remained significantly elevated in female
hypertrophied hearts compared with male hearts (24  3 vs
11  2 mmHg; p < 0.01) and nonhypertrophied female
hearts (13  3 mmHg; p < 0.05). When diastolic dysfunc-
tion was expressed as diastolic pressure/g LV, differences
between hypertrophied and nonhypertrophied hearts
were no longer present. However, female hearts again
showed persistent and increased diastolic dysfunction as
compared with hypertrophied and nonhypertrophied male
hearts during ischemia and reperfusion ( p < 0.05 and
p < 0.01, respectively, Fig. 5B). Maximal negative dp/dt
(mmHg1) paralleled diastolic pressure in all groups (data
not shown).Fig. 4. Time course of developed pressure (systolic minus diastolic LV pressure
in mmHg) shows significant differences of hypertrophied and nonhypertro-
phied hearts at baseline, independent of gender (##p < 0.01). During ischemia-
developed pressure falls to the same extent in all groups. During reperfusion
systolic function recovers better in hypertrophied male and female hearts as
compared with nonhypertrophied hearts (##p < 0.01).3.5. Pressure—volume relationship
After ischemia and reperfusion the diastolic pressure—
volume curve shifted leftward in all hearts, indicating
increased myocardial stiffness. Female hearts remained left
of male hearts ( p < 0.05; Fig. 3B). Although female
hypertrophied hearts shifted more than hypertrophied male
hearts, this difference did not reach statistical significance.
3.6. Lactate production
Cumulative lactate production per LV mass
(mmol min1 g1) was significantly higher in female hyper-
trophied than in nonhypertrophied hearts (650.8  160.1 vs
144.9  32.2; p < 0.002) and tended to be higher in male
hypertrophied than in nonhypertrophied hearts (428.5  70.9
vs 276  38.6; ns).4. Discussion
Themajorfindingsof thepresent studyare: (1) in amodelof
pressure overload (compensated state), female hearts show a
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male hearts. (2) During lowflow ischemia in females, thismore
pronounced concentric hypertrophy results in increased
susceptibility to ischemia—reperfusion injury.
4.1. Gender differences in LVH
Our study is in accordance with other experimental
studies in hypertensive hearts and different models of
pressure overload hypertrophy that showed increased
concentric hypertrophy with a predominant hypertrophy of
the septum in females compared with males after aortic
banding [2,17] and post-MI [4]. Similarly, clinical studies in
pre- and postmenopausal women showed that hypertension
and aortic stenosis were associated with increased con-
centric hypertrophy [7]. The small concentric hypertrophied
chambers result in an increased contractile function during
baseline and conversely might be responsible for the
increased diastolic dysfunction during ischemia in female
hearts (see below). The mechanisms that contribute to this
unique remodeling of the LV in pressure- and hypertension-
induced LVH in females are not entirely known. Differences in
hormonal status, i.e. an increased estrogen level or a lack of
testosterone might conceivably contribute. Estrogen has
been shown to influence cardiac hypertrophy via its
vasodilative NO-mediated properties [18]. With respect to
direct influences of estrogen on the myocardium, it has been
shown that estrogen regulates myocardial hypertrophy via
influences on MAP-kinase-phosphatase-1 (MAPK), atrial
natriuretic peptide (ANP) [6] or a modulation of the AT-1
receptor [19]. In a model of aortic constriction in ovar-
iectomized mice, 17ß-estradiol significantly decreased
hypertrophy relative to the placebo-treated mice. No effect
of 17ß-estradiol was detected in sham-operated animals nor
did 17ß-estradiol reduce cardiac fibrosis in the hypertrophied
hearts in pressure-overloaded mice. Therefore, estrogen
may prevent cardiac hypertrophy and a lack of estrogen may
play a role in the development of LV hypertrophy late in life
[20]. Similarly, estrogen and its regulatory effects on MAP-
kinase-phosphatase-1 could also be the reason for delayed
mortality and hypertrophy in female mice [21].
4.2. Gender difference in I/R injury in normotensive rats
We found no difference in the susceptibility to I/R in
normotensivemale and female rats. This is in agreement with
studies in wild-type mice where no gender difference was
found in isolated hearts undergoing an I/R protocol [17,22].
Therefore, physiological levels of estrogen in normotensive
animals seem not to exert any protective or deleterious
effect. In humans, female gender is associated with worse
prognosis in acute coronary syndromes [8,9]. Our data
suggest that differences in co-morbidity and other factors
(e.g. more left ventricular hypertrophy, smaller coronary size
etc.) might contribute greatly to this difference.
4.3. Gender differences in I/R injury in hypertrophied
hearts
We and others have repeatedly shown that pressure
overload hypertrophy increases susceptibility to I/R injury,whereby diastolic dysfunction is predominant [12,23,24]. In
the present experiments we chose a demand ischemia model
to increase the sodium load via the Na/Ca-exchanger in the
myocytes through tachycardia. Since the Dahl rat has a
mutation of the alpa1-Na, K-ATPase sodium excretion from
the myocytes could be impaired.
Surprisingly, no increase in diastolic dysfunction was found
in the male hypertrophied versus nonhypertrophied hearts in
this study. This is in agreement with previous studies in this
model, where we did not find an increased susceptibility in
male hypertensive animals after 4 weeks of high-salt diet
[14]. Left ventricular hypertrophy per se seems not in all
cases deleterious, rather the increased susceptibility of
hypertrophied hearts is dependent on the stimulus for
hypertrophy and the stage of compensation of the hyper-
trophied heart [14].
In contrast, hypertrophied females showed increased
diastolic dysfunction compared with nonhypertrophied
females and compared with male hypertrophied hearts.
Differences in blood flow could not contribute to this finding,
since coronary blood flow before and after demand ischemia
was similar in all groups. During reperfusion increased
coronary perfusion pressure in female hypertensive hearts,
however, indicates an increased vasoconstriction in these
animals.
Female hypertensive hearts also had the highest lactate
production. In this model of demand ischemia with residual
flow, a mixed aerobic and anaerobic metabolism exists. The
increased lactate production indicates greater areas of
severe underperfusion where metabolism is mainly anaero-
bic. The heterogeneous metabolism is a known phenomenon
of global ischemia in the rat heart. Areas of aerobic
conditions with near normal pH exist next to areas of severe
underperfusion and acidosis [14]. It is reasonable to
speculate that in female hypertrophied hearts with increased
concentric hypertrophy increased diastolic dysfunction
developed during demand ischemia mainly because of this
geometric difference. The increased diastolic pressure
resulted in (subendocardial) areas of severe underperfusion
with increased glycolysis and accelerated depletion of high-
energy phosphates that resulted in the poorer recovery of
these hearts.
It is important to note that in our experiments, the
perfusate contained physiological concentrations of glucose,
lactate and free fatty acids, the metabolites usually
consumed by the heart. This was deemed important since
the response to ischemia is highly dependent on the
concentrations of the metabolic substrates [25], which might
be even more important in female hearts.
In summary, the present study demonstrates that
hypertrophy is significantly higher in female than male
hypertensive rats. Furthermore, female hearts show sig-
nificantly higher LV contractile performance per LV mass. In
addition to these findings, the present study for the first time
documents that during demand ischemia this more pro-
nounced concentric hypertrophy results in no difference in
systolic function but an increase in diastolic dysfunction and
lactate production in female hypertrophied hearts compared
with female nonhypertrophied and male hearts. To deter-
mine whether in female hypertensive patients with acute
coronary syndromes diastolic dysfunction could contribute to
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